临盆产妇,纤维蛋白原如此之低,究竟是什么原因?

2022-02-21 陈旭 荆州市中心医院医学检验部 检验医学

如果遇见PT、APTT正常,而TT不明原因单独延长时,我们应该同时去做FIB的演算法和Clauss法,通过二者比值去初步判断患者是否属于遗传性纤维蛋白原血症。

案例经过

患者,女,30岁,平素月经规则,量中,无痛经史。末次月经:20210420日,预产期:20220127日。停经后有恶心等早孕反应,孕早期无阴道出血。孕4+月感胎动至今,孕期按时产检,无创DNA、系统胎儿彩超等无异常,孕妇现无阴道流水及流血,无腹痛、腹胀不适,胎动好,现来我院待产。

入院当日检查,血常规示HGB111g/L,肝肾功能正常,凝血结果示:纤维蛋白原0.83g/LTT39秒,PTAPTT正常。

图片

图片

案例分析

该患者凝血功能检测结果引起了我科血液组同事的注意,患者TT如此延长,APTTPT却正常,而电子病历显示该产妇并没有使用干扰凝血功能检测结果的药物,平时也没有出血的表现,而纤维蛋白原Clauss法结果如此之低,血液组工作人员进一步查看凝血仪器上的记录,记录显示患者纤维蛋白原演算法检测结果为8.93g/L

通过以上分析,血液组工作人员认为该患者遗传性异常纤维蛋白原血症(CD)的可能性极高。我们进一步和其管床医生联系,医生告诉我们该患者已做基因检测,其家人也将检测报告展示我们,并告诉我们患者母亲、姨表姐也曾检测凝血功能,和患者检测结果类似,均显示纤维蛋白原低下。患者基因报告检测结果如下:

该患者FGG基因编码区发生突变,c.901C>T杂合错义突变,该突变导致蛋白质第301位氨基酸从精氨酸突变成半胱氨酸(p.Arg301Cys)。

我们心中的疑惑也得到解决。

后续:患者于分娩前一天输注人纤维蛋白原2g,分娩当日复查凝血功能,FIB提高至1.02g/L。患者分娩过程顺利,产后子宫收缩好,质硬,阴道出血少。

那么,对于基层医院,并没有基因检测的手段。该如何去判断患者遗传性异常纤维蛋白原血症呢?一般情况下,患者PTAPTT正常,TT延长时,FIB的演算法结果/Clauss法结果>1.43或者Clauss法结果/演算法结果<0.7时,我们应该考虑该病的可能[1]

案例总结

CD患者,绝大多数属于常染色体显性遗传,其临床表现因人而异,同时其严重程度与FIB的突变位点及类型具有相关性,同一突变也会有不同的临床表现。可表现为出血、动静脉血栓形成,大多数患者(约55%)可无症状[2]。本案例中,患者没有自发性出血表现,孕期正常,是一位无症状的CD患者。

平时过程中,如果遇见PTAPTT正常,而TT不明原因单独延长时,我们应该同时去做FIB的演算法和Clauss法,通过二者比值去初步判断患者是否属于遗传性纤维蛋白原血症。

参考文献

[1] 周伟杰,闫婕,邓东红,等.遗传性异常纤维蛋白原血症的诊断[J].中华检验医学杂志,2020,44):406-410.

[2] 欧宁江,汤敏中. 遗传性纤维蛋白原缺陷症的研究进展[J].中国实验血液学杂志,2014224):1188-1192.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1997305, encodeId=dfe6199e305b4, content=<a href='/topic/show?id=cc04e727535' target=_blank style='color:#2F92EE;'>#纤维蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77275, encryptionId=cc04e727535, topicName=纤维蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Dec 31 06:37:44 CST 2022, time=2022-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197657, encodeId=339f119e6575d, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/22f5137b1e464c9ebdb5cf908caa3b81/8ff036c799ee492a9c61d22d0a37af15.jpg, createdBy=7d666510826, createdName=ms7000000141352835, createdTime=Sun Feb 27 07:43:19 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197633, encodeId=caca119e6334b, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e75602622, createdName=柠lemon檬, createdTime=Sat Feb 26 22:51:13 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196407, encodeId=4136119640e4f, content=受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed46518355, createdName=ms5000000909551061, createdTime=Wed Feb 23 13:34:21 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362631, encodeId=955913626313c, content=<a href='/topic/show?id=9f6ce72774d' target=_blank style='color:#2F92EE;'>#纤维蛋白原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77277, encryptionId=9f6ce72774d, topicName=纤维蛋白原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Feb 23 04:37:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196141, encodeId=45d4119614189, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:40:51 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1997305, encodeId=dfe6199e305b4, content=<a href='/topic/show?id=cc04e727535' target=_blank style='color:#2F92EE;'>#纤维蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77275, encryptionId=cc04e727535, topicName=纤维蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Dec 31 06:37:44 CST 2022, time=2022-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197657, encodeId=339f119e6575d, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/22f5137b1e464c9ebdb5cf908caa3b81/8ff036c799ee492a9c61d22d0a37af15.jpg, createdBy=7d666510826, createdName=ms7000000141352835, createdTime=Sun Feb 27 07:43:19 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197633, encodeId=caca119e6334b, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e75602622, createdName=柠lemon檬, createdTime=Sat Feb 26 22:51:13 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196407, encodeId=4136119640e4f, content=受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed46518355, createdName=ms5000000909551061, createdTime=Wed Feb 23 13:34:21 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362631, encodeId=955913626313c, content=<a href='/topic/show?id=9f6ce72774d' target=_blank style='color:#2F92EE;'>#纤维蛋白原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77277, encryptionId=9f6ce72774d, topicName=纤维蛋白原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Feb 23 04:37:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196141, encodeId=45d4119614189, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:40:51 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-27 ms7000000141352835

    受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1997305, encodeId=dfe6199e305b4, content=<a href='/topic/show?id=cc04e727535' target=_blank style='color:#2F92EE;'>#纤维蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77275, encryptionId=cc04e727535, topicName=纤维蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Dec 31 06:37:44 CST 2022, time=2022-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197657, encodeId=339f119e6575d, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/22f5137b1e464c9ebdb5cf908caa3b81/8ff036c799ee492a9c61d22d0a37af15.jpg, createdBy=7d666510826, createdName=ms7000000141352835, createdTime=Sun Feb 27 07:43:19 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197633, encodeId=caca119e6334b, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e75602622, createdName=柠lemon檬, createdTime=Sat Feb 26 22:51:13 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196407, encodeId=4136119640e4f, content=受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed46518355, createdName=ms5000000909551061, createdTime=Wed Feb 23 13:34:21 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362631, encodeId=955913626313c, content=<a href='/topic/show?id=9f6ce72774d' target=_blank style='color:#2F92EE;'>#纤维蛋白原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77277, encryptionId=9f6ce72774d, topicName=纤维蛋白原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Feb 23 04:37:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196141, encodeId=45d4119614189, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:40:51 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1997305, encodeId=dfe6199e305b4, content=<a href='/topic/show?id=cc04e727535' target=_blank style='color:#2F92EE;'>#纤维蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77275, encryptionId=cc04e727535, topicName=纤维蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Dec 31 06:37:44 CST 2022, time=2022-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197657, encodeId=339f119e6575d, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/22f5137b1e464c9ebdb5cf908caa3b81/8ff036c799ee492a9c61d22d0a37af15.jpg, createdBy=7d666510826, createdName=ms7000000141352835, createdTime=Sun Feb 27 07:43:19 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197633, encodeId=caca119e6334b, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e75602622, createdName=柠lemon檬, createdTime=Sat Feb 26 22:51:13 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196407, encodeId=4136119640e4f, content=受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed46518355, createdName=ms5000000909551061, createdTime=Wed Feb 23 13:34:21 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362631, encodeId=955913626313c, content=<a href='/topic/show?id=9f6ce72774d' target=_blank style='color:#2F92EE;'>#纤维蛋白原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77277, encryptionId=9f6ce72774d, topicName=纤维蛋白原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Feb 23 04:37:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196141, encodeId=45d4119614189, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:40:51 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-23 ms5000000909551061

    受教

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1997305, encodeId=dfe6199e305b4, content=<a href='/topic/show?id=cc04e727535' target=_blank style='color:#2F92EE;'>#纤维蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77275, encryptionId=cc04e727535, topicName=纤维蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Dec 31 06:37:44 CST 2022, time=2022-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197657, encodeId=339f119e6575d, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/22f5137b1e464c9ebdb5cf908caa3b81/8ff036c799ee492a9c61d22d0a37af15.jpg, createdBy=7d666510826, createdName=ms7000000141352835, createdTime=Sun Feb 27 07:43:19 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197633, encodeId=caca119e6334b, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e75602622, createdName=柠lemon檬, createdTime=Sat Feb 26 22:51:13 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196407, encodeId=4136119640e4f, content=受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed46518355, createdName=ms5000000909551061, createdTime=Wed Feb 23 13:34:21 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362631, encodeId=955913626313c, content=<a href='/topic/show?id=9f6ce72774d' target=_blank style='color:#2F92EE;'>#纤维蛋白原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77277, encryptionId=9f6ce72774d, topicName=纤维蛋白原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Feb 23 04:37:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196141, encodeId=45d4119614189, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:40:51 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1997305, encodeId=dfe6199e305b4, content=<a href='/topic/show?id=cc04e727535' target=_blank style='color:#2F92EE;'>#纤维蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77275, encryptionId=cc04e727535, topicName=纤维蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Sat Dec 31 06:37:44 CST 2022, time=2022-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197657, encodeId=339f119e6575d, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/22f5137b1e464c9ebdb5cf908caa3b81/8ff036c799ee492a9c61d22d0a37af15.jpg, createdBy=7d666510826, createdName=ms7000000141352835, createdTime=Sun Feb 27 07:43:19 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197633, encodeId=caca119e6334b, content=<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18e75602622, createdName=柠lemon檬, createdTime=Sat Feb 26 22:51:13 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196407, encodeId=4136119640e4f, content=受教, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed46518355, createdName=ms5000000909551061, createdTime=Wed Feb 23 13:34:21 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362631, encodeId=955913626313c, content=<a href='/topic/show?id=9f6ce72774d' target=_blank style='color:#2F92EE;'>#纤维蛋白原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77277, encryptionId=9f6ce72774d, topicName=纤维蛋白原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Feb 23 04:37:44 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196141, encodeId=45d4119614189, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:40:51 CST 2022, time=2022-02-22, status=1, ipAttribution=)]
    2022-02-22 ms2000001545439177

    受益匪浅

    0

相关资讯

过敏性肺泡炎伴呼吸衰竭产妇麻醉管理一例

产妇,34岁,50kg,G2P1,孕32+5周,因“反复咳嗽咳痰不能平卧3月余”入院,术前一般情况差,未见明显口唇紫绀,RR28次/分,HR127次/分,BP132/84mmH

2021 SMFM咨询系列#54:产妇发病和死亡的风险评估解读

母胎医学会(SMFM)发布了产妇发病和死亡的风险评估指南,主要针对产妇发病和死亡相关风险因素的评估提供指导。

JAHA:先天性心脏病妇女妊娠的产妇和新生儿结局分析

当代患有CHD的妇女妊娠通常对产妇和新生儿都有较成功的结局。然而,随着产妇CHD严重程度的增加,许多发病率和新生儿死亡率的风险也随之增加。

产妇命悬一线,敢不敢违反指南搏一搏?

这是我从医30年最艰难的一个抉择,终生难忘。

产妇坠亡事件遭“假解聘”护士返岗被拒,医院败诉1年未执行

推开备用手术室的大门,刘丽看到了正要跳楼的产妇马茸茸,她冲上去,只抓到了衣服的一角,“然后人就不见了,掉下去了。”三年前的这幕,陕西省榆林市第一医院绥德院区妇产科原助产士刘丽至

烟雾病产妇剖宫产全麻1例报告

患者,女,28岁,75kg,因“发现烟雾病2年,孕37+6周,要求入院待产”入院。2年前患者因突然出现头痛、呕吐及左上肢麻痹于医院行脑血管造影检查,诊断为烟雾病(Moyamoya disease,MMD)。经保守治疗及康复训练至今,仅遗留轻度左手肌张力增高。查体:血压121/83mmHg(1mmHg=0.133kPa),心率108min-1。